Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

NCT02964559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Skin Carcinoma
Skin Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Pembrolizumab

Sponsor

Emory University

Collaborators

[object Object]
[object Object]
[object Object]